Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11319297 | PMC |
| http://dx.doi.org/10.3389/fphar.2024.1462070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: Pharmacoinformatics: new developments and challenges in drug design.
Front Pharmacol
July 2024
DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City, Mexico.
What impact does tautomerism have on drug discovery and development?
Expert Opin Drug Discov
September 2024
Computer-Aided Drug Design Group, Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD, USA.
Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases.
Future Med Chem
September 2023
Center for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USA.
Tweetable abstract This work describes novel evidence of the relationship between NSAIDs and three prostaglandin E2 synthases.
View Article and Find Full Text PDFLatest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E synthase-1.
Future Med Chem
March 2022
Center for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USA.
Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics.
Future Med Chem
November 2021
Center for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!